Primal Therapies, Inc.

Primal Therapies, Inc. is a biotechnology company founded in 2012 with a breakthrough approach to biofilm management. Leveraging our Selective Microbial Metabolism Regulation Technology (SMMRT) platform, we’ve developed a pipeline of proprietary formulas containing active ingredients that control the behavior of harmful bacteria. Our formulas can be used across industries as solutions solving problems associated with harmful and destructive biofilms. We do not believe molecular sledgehammers (antibiotics and antiseptics) are an effective means of biofilm management. We offer the next generation of nontoxic, naturally safe solutions that neutralize harmful biofilms.